<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04736277</url>
  </required_header>
  <id_info>
    <org_study_id>HbA1c and NCD</org_study_id>
    <nct_id>NCT04736277</nct_id>
  </id_info>
  <brief_title>HbA1c and Neurocognitive Disorders</brief_title>
  <official_title>The Effect of HbA1c on Perioperative Neurocognitive Disorders in Patients Undergoing Elective Non-cardiac Surgery Under General Anesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Thessaly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Ioannina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Larissa University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Thessaly</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preliminary evidence suggest a possible relationship between HbA1c and perioperative&#xD;
      neurocognitive disorders (NCD). We are going to investigate whether the preoperative value of&#xD;
      HbA1c in patients undergoing elective non-cardiac surgery under general anesthesia, are&#xD;
      related with increased risk of perioperative NCD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is estimated that approximately 10% of elderly undergoing surgery will develop cognitive&#xD;
      changes perioperatively, while in some reports the incidence rises up to 80%. Despite the&#xD;
      reported high prevalence of perioperative neurocognitive disorders (NCD), their exact&#xD;
      etiology is still largely unknown.&#xD;
&#xD;
      Preliminary evidence suggest a possible relationship between HbA1c and perioperative&#xD;
      neurocognitive disorders (NCD). We are going to investigate whether the preoperative value of&#xD;
      HbA1c in patients undergoing elective non-cardiac surgery under general anesthesia, are&#xD;
      related with increased risk of perioperative NCD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2015</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Actual">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Postoperative Neurocognitive Disorders assessed with CAM</measure>
    <time_frame>1st postoperative day</time_frame>
    <description>Screening for POD assessed with CAM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Postoperative Neurocognitive Disorders with IQCODE-16</measure>
    <time_frame>10th postoperative day</time_frame>
    <description>Screening for POCD with IQCODE-16</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Postoperative Neurocognitive Disorders with IQCODE-16</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>Screening for POCD with IQCODE-16</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Postoperative Neurocognitive Disorders with IQCODE-16</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>Screening for POCD with IQCODE-16</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Postoperative Neurocognitive Disorders with IQCODE-16</measure>
    <time_frame>9 months postoperatively</time_frame>
    <description>Screening for POCD with IQCODE-16</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Neurocognitive Disorders</condition>
  <condition>HbA1c</condition>
  <arm_group>
    <arm_group_label>Noncardiac surgery</arm_group_label>
    <description>Documentation of HbA1c in patients undergoing noncardiac surgery under general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preoperative HbA1c</intervention_name>
    <description>Documentation of the preopetative HbA1c in patients undergoing noncardiac surgery under general anesthesia</description>
    <arm_group_label>Noncardiac surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - All patients 45 - 80 years old, ASA I-III undergoing elective general, urological,&#xD;
        gynecological and orthopedic surgery under general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1) 45 - 80 years&#xD;
&#xD;
          -  2) American Society of Anesthesiologists physical status I to III&#xD;
&#xD;
          -  3) elective general, urological, gynecological and orthopedic surgery under general&#xD;
             anesthesia&#xD;
&#xD;
          -  4) native speakers of the Greek language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) refused to participate or sign the informed consent form&#xD;
&#xD;
          -  2) had undergone surgery or anesthesia within the last 30 days&#xD;
&#xD;
          -  3) had any prior or current history involving an affliction of the central nervous&#xD;
             system&#xD;
&#xD;
          -  4) were diagnosed with severe cognitive decline based on the 16 - item Informant&#xD;
             Questionnaire on Cognitive Decline (IQCODE - 16)&#xD;
&#xD;
          -  5) suffered from severe hearing or visual impairment&#xD;
&#xD;
          -  6) any psychiatric disorder&#xD;
&#xD;
          -  7) had a score &gt;5 in the Geriatric Depression Scale (GDS - 15)&#xD;
&#xD;
          -  8) or a score in females &lt; 4 males &lt; 2 in the Lawton - Brody Instrumental Activities&#xD;
             of Daily Living Scale (I.A.D.L.)&#xD;
&#xD;
          -  9) reported alcohol consumption &gt; 35 units/week&#xD;
&#xD;
          -  10) drug dependence&#xD;
&#xD;
          -  11) had undergone previous neuropsychological testing&#xD;
&#xD;
          -  12) Diabetes Mellitus type II with &gt; 10 years of diagnosis&#xD;
&#xD;
          -  13) Diabetes Mellitus type I&#xD;
&#xD;
          -  14) Hemoglobin A1c (HbA1c) &gt; 7.5%&#xD;
&#xD;
          -  15) suffered from hemodynamical instability (&gt; 20% alterations of blood pressure&#xD;
             perioperatively)&#xD;
&#xD;
          -  16) or desaturation (one or more events of SpO2 &lt; 80% for more than 2 minutes)&#xD;
             peri-operatively&#xD;
&#xD;
          -  17) or blood loss of more than one unit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Eleni Arnaoutoglou, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Ntalouka, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Ntalouka, MD, PhD</last_name>
    <phone>+306973688099</phone>
    <email>maria.ntalouka@icloud.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Metaxia Bareka, MD, PhD</last_name>
    <phone>+306947845083</phone>
    <email>barekametaxia@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Thessaly</name>
      <address>
        <city>Larissa</city>
        <zip>41335</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleni Arnaoutoglou, MD, PhD</last_name>
      <phone>+306974301352</phone>
      <email>earnaout@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Ntalouka, MD, PhD</last_name>
      <phone>+306973688099</phone>
      <email>maria.ntalouka@icloud.com</email>
    </contact_backup>
    <investigator>
      <last_name>Eleni Arnaoutoglou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Ntalouka, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petros Tzimas, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandros Brotis, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fragkiskos Angelis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Metaxia Bareka, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 24, 2020</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Thessaly</investigator_affiliation>
    <investigator_full_name>Elena Arnaoutoglou</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurocognitive Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

